Breast Cancer Incidence in Relation to Long-Term Low-Level Exposure to Air Pollution in the ELAPSE Pooled Cohort.


Journal

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
ISSN: 1538-7755
Titre abrégé: Cancer Epidemiol Biomarkers Prev
Pays: United States
ID NLM: 9200608

Informations de publication

Date de publication:
09 01 2023
Historique:
received: 24 06 2022
revised: 09 09 2022
accepted: 05 10 2022
pubmed: 11 10 2022
medline: 11 1 2023
entrez: 10 10 2022
Statut: ppublish

Résumé

Established risk factors for breast cancer include genetic disposition, reproductive factors, hormone therapy, and lifestyle-related factors such as alcohol consumption, physical inactivity, smoking, and obesity. More recently a role of environmental exposures, including air pollution, has also been suggested. The aim of this study, was to investigate the relationship between long-term air pollution exposure and breast cancer incidence. We conducted a pooled analysis among six European cohorts (n = 199,719) on the association between long-term residential levels of ambient nitrogen dioxide (NO2), fine particles (PM2.5), black carbon (BC), and ozone in the warm season (O3) and breast cancer incidence in women. The selected cohorts represented the lower range of air pollutant concentrations in Europe. We applied Cox proportional hazards models adjusting for potential confounders at the individual and area-level. During 3,592,885 person-years of follow-up, we observed a total of 9,659 incident breast cancer cases. The results of the fully adjusted linear analyses showed a HR (95% confidence interval) of 1.03 (1.00-1.06) per 10 μg/m³ NO2, 1.06 (1.01-1.11) per 5 μg/m³ PM2.5, 1.03 (0.99-1.06) per 0.5 10-5 m-1 BC, and 0.98 (0.94-1.01) per 10 μg/m³ O3. The effect estimates were most pronounced in the group of middle-aged women (50-54 years) and among never smokers. The results were in support of an association between especially PM2.5 and breast cancer. The findings of this study suggest a role of exposure to NO2, PM2.5, and BC in development of breast cancer.

Sections du résumé

BACKGROUND
Established risk factors for breast cancer include genetic disposition, reproductive factors, hormone therapy, and lifestyle-related factors such as alcohol consumption, physical inactivity, smoking, and obesity. More recently a role of environmental exposures, including air pollution, has also been suggested. The aim of this study, was to investigate the relationship between long-term air pollution exposure and breast cancer incidence.
METHODS
We conducted a pooled analysis among six European cohorts (n = 199,719) on the association between long-term residential levels of ambient nitrogen dioxide (NO2), fine particles (PM2.5), black carbon (BC), and ozone in the warm season (O3) and breast cancer incidence in women. The selected cohorts represented the lower range of air pollutant concentrations in Europe. We applied Cox proportional hazards models adjusting for potential confounders at the individual and area-level.
RESULTS
During 3,592,885 person-years of follow-up, we observed a total of 9,659 incident breast cancer cases. The results of the fully adjusted linear analyses showed a HR (95% confidence interval) of 1.03 (1.00-1.06) per 10 μg/m³ NO2, 1.06 (1.01-1.11) per 5 μg/m³ PM2.5, 1.03 (0.99-1.06) per 0.5 10-5 m-1 BC, and 0.98 (0.94-1.01) per 10 μg/m³ O3. The effect estimates were most pronounced in the group of middle-aged women (50-54 years) and among never smokers.
CONCLUSIONS
The results were in support of an association between especially PM2.5 and breast cancer.
IMPACT
The findings of this study suggest a role of exposure to NO2, PM2.5, and BC in development of breast cancer.

Identifiants

pubmed: 36215200
pii: 709688
doi: 10.1158/1055-9965.EPI-22-0720
doi:

Substances chimiques

Particulate Matter 0
Nitrogen Dioxide S7G510RUBH
Air Pollutants 0
Ozone 66H7ZZK23N

Types de publication

Journal Article Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

105-113

Subventions

Organisme : Medical Research Council
ID : MR/S019669/1
Pays : United Kingdom

Informations de copyright

©2022 American Association for Cancer Research.

Auteurs

Ulla Arthur Hvidtfeldt (UA)

Danish Cancer Society Research Center, Copenhagen, Denmark.

Jie Chen (J)

Institute for Risk Assessment Sciences, Utrecht University, Utrecht, the Netherlands.

Sophia Rodopoulou (S)

Department of Hygiene, Epidemiology and Medical Statistics, Medical School, National and Kapodistrian University of Athens, Athens, Greece.

Maciej Strak (M)

Institute for Risk Assessment Sciences, Utrecht University, Utrecht, the Netherlands.
National Institute for Public Health and the Environment, Bilthoven, the Netherlands.

Kees de Hoogh (K)

Swiss Tropical and Public Health Institute and University of Basel, Basel, Switzerland.

Zorana J Andersen (ZJ)

Department of Public Health, University of Copenhagen, Copenhagen, Denmark.

Tom Bellander (T)

Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.
Centre for Occupational and Environmental Medicine, Region Stockholm, Stockholm, Sweden.

Jørgen Brandt (J)

Department of Environmental Science, Aarhus University, Roskilde, Denmark.
iClimate - interdisciplinary Centre for Climate Change, Aarhus University, Roskilde, Denmark.

Daniela Fecht (D)

MRC Centre for Environment and Health, School of Public Health, Imperial College London, London, United Kingdom.

Francesco Forastiere (F)

Department of Epidemiology, Lazio Region Health Service/ASL Roma 1, Rome, Italy.
Environmental Research Group, School of Public Health, Faculty of Medicine, Imperial College, London, United Kingdom.

John Gulliver (J)

MRC Centre for Environment and Health, School of Public Health, Imperial College London, London, United Kingdom.
Centre for Environmental Health and Sustainability & School of Geography, Geology and the Environment, University of Leicester, Leicester, United Kingdom.

Ole Hertel (O)

Departments of Ecoscience, Aarhus University, Roskilde, Denmark.

Barbara H Hoffmann (BH)

Institute for Occupational, Social and Environmental Medicine, Centre for Health and Society, Medical Faculty, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.

Klea Katsouyanni (K)

Department of Hygiene, Epidemiology and Medical Statistics, Medical School, National and Kapodistrian University of Athens, Athens, Greece.
MRC Centre for Environment and Health, School of Public Health, Imperial College London, London, United Kingdom.

Matthias Ketzel (M)

Department of Environmental Science, Aarhus University, Roskilde, Denmark.
Global Centre for Clean Air Research (GCARE), University of Surrey, Guildford, United Kingdom.

Boel Brynedal (B)

Department of Global Public Health, Karolinska Institutet, Stockholm, Sweden.

Karin Leander (K)

Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.

Petter L S Ljungman (PLS)

Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.
Department of Cardiology, Danderyd University Hospital, Stockholm, Sweden.

Patrik K E Magnusson (PKE)

Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.

Gabriele Nagel (G)

Institute of Epidemiology and Medical Biometry, Ulm University, Ulm, Germany.

Göran Pershagen (G)

Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.
Centre for Occupational and Environmental Medicine, Region Stockholm, Stockholm, Sweden.

Debora Rizzuto (D)

Department of Neurobiology, Care Sciences, and Society, Karolinska Institutet and Stockholm University, Stockholm, Sweden.
Stockholm Gerontology Research Center, Stockholm, Sweden.

Marie-Christine Boutron-Ruault (MC)

University Paris-Saclay, UVSQ, Inserm, Gustave Roussy, "Exposome and Heredity" team, CESP UMR1018, Villejuif, France.

Evangelia Samoli (E)

Department of Hygiene, Epidemiology and Medical Statistics, Medical School, National and Kapodistrian University of Athens, Athens, Greece.

Rina So (R)

Department of Public Health, University of Copenhagen, Copenhagen, Denmark.

Massimo Stafoggia (M)

Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.
Department of Epidemiology, Lazio Region Health Service/ASL Roma 1, Rome, Italy.

Anne Tjønneland (A)

Danish Cancer Society Research Center, Copenhagen, Denmark.
Department of Public Health, University of Copenhagen, Copenhagen, Denmark.

Roel Vermeulen (R)

Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.

W M Monique Verschuren (WMM)

National Institute for Public Health and the Environment, Bilthoven, the Netherlands.
Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.

Gudrun Weinmayr (G)

Institute of Epidemiology and Medical Biometry, Ulm University, Ulm, Germany.

Kathrin Wolf (K)

Institute of Epidemiology, Helmholtz Zentrum München, Neuherberg, Germany.

Jiawei Zhang (J)

Department of Public Health, University of Copenhagen, Copenhagen, Denmark.

Emanuel Zitt (E)

Agency for Preventive and Social Medicine (aks), Bregenz, Austria.
Department of Internal Medicine 3, LKH Feldkirch, Feldkirch, Austria.

Bert Brunekreef (B)

Institute for Risk Assessment Sciences, Utrecht University, Utrecht, the Netherlands.

Gerard Hoek (G)

Institute for Risk Assessment Sciences, Utrecht University, Utrecht, the Netherlands.

Ole Raaschou-Nielsen (O)

Danish Cancer Society Research Center, Copenhagen, Denmark.
Department of Environmental Science, Aarhus University, Roskilde, Denmark.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH